Veeva’s Study Builder Agent aims to configure clinical trials in a day

Veeva Systems announced Veeva Study Builder Agent, an AI solution that configures Veeva EDC and Veeva DQS directly from a study protocol, reusing an organization’s existing standards and the CDISC Unified Study Definitions Model (USDM). Early adopter availability is planned for December 2026; it ships as part of EDC with no additional license and is delivered as a Claude Cowork plugin from a Veeva-managed GitHub repository.

HEALTH desk — clinical-trial plumbing is becoming agent work; the risk is not speed — it is whether an automated build still matches the protocol regulators will audit.

What the agent configures, on the release. It configures EDC forms, visits, and edit-check rules, plus CQL-based listings in DQS. It also automates testing, including the generation of test data. A form is the screen a research site fills in. A visit is a scheduled point in the trial, such as screening or a follow-up. An edit check is a rule that flags an entry that does not fit, such as a date that cannot be true. A listing is a table of the collected data that a reviewer reads. CQL, in Veeva’s own clinical-data documentation, is Clinical Query Language, the query language those listings are written in. The 24 Sep release does not spell those letters out. That expansion stays off the wire. Test data is made-up patient data used to try the build before a real site enters a real person. These configuration lines are the release’s. This desk did not generate a test patient.

How the release says the build stays on the rails. By reusing an organization’s existing standards and using the CDISC Unified Study Definitions Model (USDM), the agent is supposed to produce faster, more deterministic study builds. CDISC is the standards group that publishes shared formats for clinical-trial data. That gloss is this desk’s. The release prints the name and does not expand the letters. USDM is the shared model for describing a study so different software can read one definition. Deterministic, here, means the same protocol and the same standards should come out as the same build, not a different one each time the agent runs. Because the agent builds from the organization’s existing standards and follows a coordinated process, the release says the results minimize deviation from standards and are audit-ready by design. Audit-ready means a reviewer can trace the build back to those standards and to the protocol. Faster, more deterministic, minimize deviation, and audit-ready by design are the company’s claims. This desk did not compare two builds, and it did not sit an auditor down with one.

The headline clock, and the sentence that is not a stopwatch. The headline says the agent will configure clinical studies in as little as one day. “As little as” is the headline’s hedge. It is a company claim about the short end of the range. It is not a timed build this desk watched. Drew Garty, chief technology officer of Veeva Clinical Data, said Veeva Study Builder Agent will make it much faster to build high-quality studies. He said the company is committed to innovations that simplify, standardize, and connect clinical trials, and that Study Builder Agent is a significant step toward that vision. “Much faster” and “significant step” are his words on the wire. They are not a day-count sitting beside the headline. This desk did not interview him.

When a customer can get it, what it costs, and how it arrives. Planned early adopter availability is December 2026. Early adopter means a first group of customers. The release does not call that a general release, and it does not print a day inside December. The agent is part of EDC and requires no additional license. No additional license means a customer who already has EDC does not buy a second product to turn this on. The page does not print a dollar price, a customer name, or a count of early adopters. Do not invent them. It is delivered as a Claude Cowork plugin and installed from a Veeva-managed GitHub repository. A plugin is an add-on. Claude Cowork is the Anthropic product the release names as the place that plugin installs. The page does not explain Cowork further. GitHub is the code host. Veeva-managed means Veeva runs the repository. The page does not print the repository URL. These lines are the release’s. This desk did not install the plugin.

The summit, and the product the release does not say the agent builds. The same paragraph says to learn more about Veeva Clinical Data solutions, including EDC, DQS, and eCOA, at the Veeva R&D and Quality Summit in Boston on October 20-21. The event is open exclusively to life sciences industry professionals. eCOA, in clinical-trial speech, is an electronic record of how a patient reports an outcome, such as a symptom score. That gloss is this desk’s. The release lists eCOA as something to learn about at the summit. It does not say the agent configures eCOA. October 20-21 is the summit. December 2026 is the early-adopter window. They are not the same date. The release links the summit at veeva.com/events/rd-summit/. These lines are the release’s.

The same sentences on Veeva’s own news page, and the clocks that page does not print. Veeva’s newsroom reprint, at veeva.com/resources/new-veeva-study-builder-agent-to-configure-clinical-studies-in-as-little-as-one-day/, carries the same headline, the same subhead, the same lede, the same configuration paragraph, the same Garty quote, the same December and plugin paragraph, the same about box, and the same forward-looking paragraph. Its dateline reads PLEASANTON, CA — Sept. 24, 2026. The body this desk read does not print 07:03 ET. That stamp is the PR Newswire line. The reprint is the company’s own posting of the release. It is not a second announcement with new numbers.

What the EDC product page adds, and what it does not let you file as an agent result. The EDC page the release links, veeva.com/products/veeva-edc/, carries an alert: “Introducing Veeva Study Builder Agent to configure studies in as little as one day.” That alert links to the newsroom reprint. Under it, a separate block labeled Impact, headed “Proven value for complex studies,” prints 50% faster study builds, 100% elimination of known custom functions, and 9x faster to implement study changes. Those three figures sit in the EDC product block. They are not sentences in the 24 Sep release. Do not file them as measured results for Study Builder Agent. Higher on the same page, the EDC product card says Announced 2016, Status Mature, and Customers 100+. Those lines describe EDC, the product that has been on the market since 2016. They are not a description of an agent whose early adopters are planned for December 2026. The DQS product page the release links, veeva.com/products/veeva-dqs/, did not print Study Builder Agent on the fetch this desk made. This desk did not open a Vault account.

What the about box and the caution say. Veeva delivers the industry cloud for life sciences, with applications, agents, data, and consulting. It serves more than 1,500 customers, from the world’s largest pharmaceutical companies to emerging biotechs. It is a Public Benefit Corporation. The box says Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. A public benefit corporation, in plain words, is a company whose charter names more than the shareholders. That definition is this desk’s, not a second sentence on the page. The site is veeva.com. The forward-looking paragraph says the release contains statements about products and expected benefits, that those statements are based on current expectations, that actual results could differ, and that Veeva has no obligation to update them. It points at the Form 10-Q for the fiscal year ended July 31, 2026, and says a summary of risks is on pages 33 and 34, with later filings at sec.gov. Those page numbers are the release’s pointer. This desk did not open the 10-Q. The “as little as one day” headline, the “faster” and “more deterministic” lines, and “audit-ready by design” sit inside that caution. They are plans and claims, not a result this desk timed. The contact is parked in the source note.

Plain English for the rest of the card. EDC = electronic data capture, the digital forms and rules that run a trial. A protocol = the written plan for the study. DQS = Veeva’s Data Quality System. A form = the screen a site fills in. A visit = a scheduled point in the trial. An edit check = a rule that flags a bad entry. A listing = a table a reviewer reads. CQL = Clinical Query Language in Veeva’s own docs; the wire does not spell it out. USDM = the CDISC Unified Study Definitions Model, a shared description of a study. CDISC = the standards group behind that model. Deterministic = the same inputs should make the same build. Audit-ready = a reviewer can trace the build to the standards and the protocol. That is the company’s claim. Test data = made-up data used to try the build. Early adopter = a first group of customers, planned for December 2026, with no day printed. No additional license = it comes with EDC. A plugin = an add-on. Claude Cowork = the Anthropic product the release names as where that add-on installs. GitHub = the code host. The page does not print the repository URL. eCOA = an electronic patient-outcome record, named as a summit topic, not as something this agent configures. October 20-21 = the Boston summit. 07:03 ET = the wire’s stamp, 11:03 UTC. 1,500 = the about box’s customer floor. 2016, Mature, and 100+ = the EDC product card, not this agent. 50%, 100%, and 9x = the EDC page’s Impact block, not sentences on the 24 Sep wire. This filing is the 24 Sep announcement.

PRIMARY here: Veeva’s 24 Sep 2026 PR Newswire release, stamp Sep 24, 2026, 07:03 ET, datelined Pleasanton — Tier A PRIMARY, the company’s own announcement. The newsroom page on veeva.com is the same release without the 07:03 stamp. The EDC product page is a banner pointing at that reprint, plus an older EDC impact block that this filing does not treat as the agent’s result. The announcement, the EDC and DQS configuration list, the forms, visits, edit checks, CQL listings, and test-data lines, the standards and USDM sentence, the minimize-deviation and audit-ready sentence, the “as little as one day” headline, the Garty quote, December 2026, no additional license, the Claude Cowork plugin, the Veeva-managed GitHub line with no URL, the Boston summit on October 20-21, the eCOA mention, the about box, the 1,500-customer line, the public-benefit sentence, and the 10-Q pointer to pages 33 and 34 are the release’s. The 50%, 100%, and 9x figures, and the 2016 / Mature / 100+ card, are the EDC product page’s. NOT claimed: that this desk timed a one-day build, that “as little as one day” is a measured average, a dollar price, a named early adopter, a count of adopters, a day inside December, a GitHub URL, that the agent configures eCOA, that the EDC impact percentages are this agent’s results, that this desk opened the 10-Q or installed the plugin, a stock tip, or investment advice. The card image is omitted. Distinct from the already-filed grail-galleri-fda-panel, oracle-health-oncology-ehr, qualtrics-healthcare-xm, and openai-australia-medicare-agent.